ImmuCell Corporation will announce its unaudited financial results for the quarter ended September 30, 2026, after market close on November 12, 2026. The company will hold a conference call and webcast on November 13 to discuss the results. Preliminary sales results showed a 46% increase in product sales for Q3 2026, indicating strong business performance. ImmuCell specializes in animal health biologics, focusing on calf health products to combat neonatal calf diarrhea.
ImmuCell's upcoming unaudited financial results provide context for readers interested in health-related stocks. For readers following the health sector, here is Pluang's market snapshot as of Nov 07, 2026 04:02 WIB: out of 150 priced health-sector US stocks, 77 rose and 72 fell. Notable movers include CGC at USD 0.67 with a 1-day change of -10.87%, DFTX at USD 33.31 with +9.72%, and IMVT at USD 31.09 with +9.51%.
Arcutis Biotherapeutics awarded 58,500 restricted stock units and options for 17,000 shares to six new employees as an inducement to join the company. The grants, approved under Nasdaq Listing Rule 5635(c)(4), vest over four years with specific sched...
The music duo for KING + COUNTRY released the Drummer Boy (Original Motion Picture Soundtrack) to coincide with the nationwide launch of their Christmas film DRUMMER BOY. The soundtrack features original songs by Joel and Luke Smallbone, reimagined C...
HMG Strategy is holding its first Tennessee C-Level Technology Leadership Summit on November 13 at W Nashville, bringing together CIOs, CISOs, CTOs, and senior tech executives from across Tennessee and the Mid-South. The summit will focus on AI, cybe...
Two large transfers of Tether USDt (USDT) totaling over 81 million tokens were recorded moving from unidentified wallets to Coinbase in early November. On November 1, 40 million USDT moved to Coinbase, followed by a 41,048,700 USDT transfer on Novemb...
OpenAI has raised $11 billion so far in a new funding round valuing the company at $1.25 trillion, with the round expected to close at around $20 billion. This funding round is smaller than the initially targeted $30 billion. The AI market faces unce...
